Drugs / Autovaccine Symbiopharm
last change Jun 2011 re-read 3 minutes ago

Autovaccine Symbiopharm

Vaccine

Developed for
house allergic alveolitis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1 NCT00677209 Comparator Jul 2006 → Aug 2008 house allergic alveolitis Johann Wolfgang Goethe University Hospital Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Autovaccine Symbiopharm ClinicalTrials.gov intervention name — accepted as the source's own label NCT00677209 ↗
Modality Vaccine “autologous E.coli autovaccine” PMID 21639872 ↗ Jun 2011